Trial intelligence / Profile preview

Topical Bimatoprost for Migraine Prevention

NCT03419715Phase 2Unknown

Sponsor
Manistee Partners
Start
Jan 2018
Primary completion
Apr 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of bimatoprost in migraine, sponsored by Manistee Partners. Status: unknown.

02

Drugs

bimatoprost
03

Conditions

migraine

Beyond the preview

Go deeper on NCT03419715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03419715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call